Low IGF-1 levels in extremely preterm infants (gestational age [GA] of 23 weeks +0 days to 27 weeks +6 days) are a risk factor for CLD and other complications of extreme prematurity. An increase of serum IGF-1 levels provided by SHP607 administration may reduce the incidence of CLD and other complications of extreme prematurity.
Articles
November 20, 2023
During the holidays we can sometimes lose sight of our healthy eating practices. Our registered dietitians have compiled eight tips to keep us on track!